Impact of Professional Continuous Glucose Monitors in an Ambulatory Clinic
by Ashley Moore, PharmD, Julie Bartell, PharmD, BCACP
"Continuous glucose monitoring (CGM) systems have been rapidly gaining popularity over the last few years, as they serve as alternatives to traditional self-monitoring blood glucose (SMBG) methods. CGMs automatically measure interstitial glucose levels every few minutes through a microfilament sensor inserted under the patient's skin. The capability of CGMs to provide daily glycemic trends is a valuable tool to help guide clinical decision-making. This technology can help patients and providers make informed decisions based on glucose trends and offers an advantage over SMBG, which is limited by the need for frequent testing and the difficulty of reporting accurate results."
Keywords: Glycated Hemoglobin A, Blood Glucose, Diabetes Mellitus, Type 1, meglitinide, Insulin, Diabetes Mellitus, Type 2, Blood Glucose Self-Monitoring, Glucose, Retrospective Studies, Calibration, Consensus, United States Food and Drug Administration, Outpatients, Endocrinologists, Insurance Carriers, Standard of Care, Medicare, Hypoglycemia, Hypoglycemic Agents, Clinical Decision-Making
Download PDF
2021 November/December Table of Contents
"Continuous glucose monitoring (CGM) systems have been rapidly gaining popularity over the last few years, as they serve as alternatives to traditional self-monitoring blood glucose (SMBG) methods. CGMs automatically measure interstitial glucose levels every few minutes through a microfilament sensor inserted under the patient's skin. The capability of CGMs to provide daily glycemic trends is a valuable tool to help guide clinical decision-making. This technology can help patients and providers make informed decisions based on glucose trends and offers an advantage over SMBG, which is limited by the need for frequent testing and the difficulty of reporting accurate results."
Keywords: Glycated Hemoglobin A, Blood Glucose, Diabetes Mellitus, Type 1, meglitinide, Insulin, Diabetes Mellitus, Type 2, Blood Glucose Self-Monitoring, Glucose, Retrospective Studies, Calibration, Consensus, United States Food and Drug Administration, Outpatients, Endocrinologists, Insurance Carriers, Standard of Care, Medicare, Hypoglycemia, Hypoglycemic Agents, Clinical Decision-Making
Download PDF
2021 November/December Table of Contents